Balyasny Asset Management LLC Biomea Fusion, Inc. Transaction History
Balyasny Asset Management LLC
- $58 Billion
- Q3 2024
A detailed history of Balyasny Asset Management LLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 40,477 shares of BMEA stock, worth $171,217. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,477
Previous 15,699
157.83%
Holding current value
$171,217
Previous $70,000
482.86%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BMEA
# of Institutions
104Shares Held
17.8MCall Options Held
1.68MPut Options Held
410K-
Cormorant Asset Management, LP Boston, MA3.57MShares$15.1 Million2.53% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$9.92 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$8.92 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$5.91 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.38MShares$5.83 Million0.01% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $124M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...